SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Thyrocare Technologies informs about appointment of chief commercial officer

23 Feb 2024 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), Thyrocare Technologies has informed that, Nitin Chugh has been appointed as Chief Commercial Officer of the Company, being part of the Senior Management of the Company with effect from February 22, 2024. Further, the details/disclosures required under Regulation 30 of the SEBI Listing Regulations, read the SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 and SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, are enclosed as Annexure -A.

The above information is a part of company’s filings submitted to BSE.

Thyrocare Tech. Share Price

392.05 4.20 (1.08%)
22-Apr-2026 12:17 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×